Cytomegalovirus in hematopoietic stem cell transplant recipients
- PMID: 21236396
- PMCID: PMC3340426
- DOI: 10.1016/j.hoc.2010.11.011
Cytomegalovirus in hematopoietic stem cell transplant recipients
Abstract
This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.
Copyright © 2011 Elsevier Inc. All rights reserved.
Republished from
-
Cytomegalovirus in hematopoietic stem cell transplant recipients.Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008. Infect Dis Clin North Am. 2010. PMID: 20466273 Review.
References
-
- Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 2008;325:63–83. - PubMed
-
- Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood. 1999;93(1):394–8. - PubMed
-
- Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, et al. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991;72(Pt 9):2059–64. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
